A 33-year diagnostic odyssey in an Ashkenazi Jewish patient with Aicardi-Goutières syndrome
The critical need for awareness and genetic testing of the SAMHD1 deletion in Ashkenazi Jewish patients is highlighted owing to its relatively high carrier frequency. Early detection can prevent severe disease complications through targeted therapy.
Enregistré dans:
| Auteurs principaux: | , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Elsevier
2025-05-01
|
| Collection: | Journal of Allergy and Clinical Immunology: Global |
| Sujets: | |
| Accès en ligne: | http://www.sciencedirect.com/science/article/pii/S2772829325000013 |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|